Metabolic and endocrinological effects of weekly growth hormone replacement therapy with somapacitan in patients with adult growth hormone deficiency after switching from daily growth hormone replacement therapy: A real-world exploratory cohort study
Drug Discoveries & Therapeutics · 30.06.2026 · 20 (3) · 221-227
DOI: 10.5582/ddt.2026.01003 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 30.06.2026. Verfasst von Ichiro Abe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan. Hauptthemen laut MEDLINE: Human Growth Hormone, Hormone Replacement Therapy. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.
- Department of Internal Medicine, Nagasaki Prefecture Iki Hospital, Iki, Nagasaki, Japan.
- Clinical Research Support Center, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.
- Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Zitieren
APA
Abe, I., Kubo, K., Fujita, Y., Ochi, K., Wada, T., Mitsuoka, R., Takeshita, K., Higashi, A., Kato, T., Kudo, T., Shimada, H., Imakyure, O., Abe, M., Mukoubara, S., & Kobayashi, K. (2026). Metabolic and endocrinological effects of weekly growth hormone replacement therapy with somapacitan in patients with adult growth hormone deficiency after switching from daily growth hormone replacement therapy: A real-world exploratory cohort study. Drug Discoveries & Therapeutics, 20(3), 221-227. https://doi.org/10.5582/ddt.2026.01003
Vancouver
Abe I, Kubo K, Fujita Y, Ochi K, Wada T, Mitsuoka R, et al. Metabolic and endocrinological effects of weekly growth hormone replacement therapy with somapacitan in patients with adult growth hormone deficiency after switching from daily growth hormone replacement therapy: A real-world exploratory cohort study. Drug Discoveries & Therapeutics. 2026;20(3):221-227. doi:10.5582/ddt.2026.01003
BibTeX
@article{Abe2026,
author = {Abe, Ichiro and Kubo, Keita and Fujita, Yuya and Ochi, Kentaro and Wada, Toshiaki and Mitsuoka, Ryo and Takeshita, Kaori and Higashi, Ayuko and Kato, Tamotsu and Kudo, Tadachika and Shimada, Hideaki and Imakyure, Osamu and Abe, Makiko and Mukoubara, Shigeaki and Kobayashi, Kunihisa},
title = {Metabolic and endocrinological effects of weekly growth hormone replacement therapy with somapacitan in patients with adult growth hormone deficiency after switching from daily growth hormone replacement therapy: A real-world exploratory cohort study},
journal = {Drug Discoveries & Therapeutics},
year = {2026},
volume = {20},
number = {3},
pages = {221--227},
doi = {10.5582/ddt.2026.01003}
}
EUVIMED